[ad_1]
Forums –
As cancer spread around the world, scientists looked for drugs to limit it. According to statistics from the World Health Organization, prostate cancer is the second most important cancer in men after lung cancer, affecting more than a million people worldwide in 2012
In this regard, a recent US study was conducted on the drug Finasteride, used to treat prostate hypertrophy, which could reduce the risk of prostate cancer.
The study was conducted by researchers at the SWOG Cancer Research Network, an international group of clinical trials funded by the US National Cancer Institute.
The team studied the efficacy of finasteride and its effect on improving urinary flow and treating urinary tract problems.
The team conducted one of the largest clinical trials ever conducted on prostate cancer, involving more than 300,000 prostate cancer patients over the last two decades.
The results showed that finasteride had a lasting effect on people who took it to reduce the risk of prostate cancer compared to their peers who took a placebo.
The researchers found that this drug reduces the risk of prostate cancer by 25%.
Source link
